Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
ALPHARETTA, Ga. , Nov. 7, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner, senior vice president, chief financial o
Avanos Medical Inc. (NYSE:AVNS ) Q3 2023 Earnings Conference Call November 1, 2023 9:00 AM ET Company Participants Scott Galovan - SVP, Strategy and Corporate Development Joseph Woody - CEO Michael Gr
ALPHARETTA, Ga. , Oct. 25, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2023 on W
ALPHARETTA, Ga. , Sept. 12, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer, and chief transformation offic
Despite strength in Avanos' (AVNS) Digestive Health segment, its overall second-quarter results reflect soft performances.
Avanos Medical Inc. (NYSE:AVNS ) Q2 2023 Results Conference Call August 9, 2023 9:00 AM ET Company Participants Joe Woody - CEO and Director Scott Galovan - Vice President of Strategy and Corporate De
ALPHARETTA, Ga. , Aug. 2, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2023 on W
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Avanos Medical (AVNS) and Edwards Lifesciences (EW). But which of these two stocks offers value inve
Avanos Medical, Inc. (AVNS) continues its focus on a leaner cost structure and repurposing of capital. The struggling respiratory health business has been sold off, with the transaction due to settle
Avanos' (AVNS) latest acquisition is expected to strengthen its foothold with a comprehensive suite of RF offerings.
Despite strength in Avanos' (AVNS) Chronic Care segment, its overall first-quarter results reflect soft performances.
Avanos Medical (AVNS) came out with quarterly earnings of $0.27 per share, missing the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.26 per share a year ago.
Avanos Medical: Cost Restructuring Could Unlock Substantial Value.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE